Mnitoring the API in Lilly manufa. plants

[Anonymous]

Does Eli Lilly and Company monitor the blood exposure of active pharmaceutical ingredients (API) and final product in thier employees at their manufacturing plants worldwide.

It seems plausible that primary and secondary APIs, and final products may be present at higher plasma concentration in these employees than say employees at the Corporate Headquarters. If Lilly implements such monitoring practices, how the data looks like for the primary and secondary API exposure.

 

[Anonymous]

As per Justice Dept.'s CIA, the MINOTAUR of FIPNet monitors all and nothing at the same time! It is foretold in prophecy of the MYSTERY·HARLOT: LILLY!

 

[Anonymous]

Does Eli Lilly and Company monitor the blood exposure of active pharmaceutical ingredients (API) and final product in thier employees at their manufacturing plants worldwide.

It seems plausible that primary and secondary APIs, and final products may be present at higher plasma concentration in these employees than say employees at the Corporate Headquarters. If Lilly implements such monitoring practices, how the data looks like for the primary and secondary API exposure.

Funny you should mention that. Of course not, it is not required by law.

 

[Anonymous]

Funny you should mention that. Of course not, it is not required by law.

I thought OSHA/EPA rules would require companies like Lilly to monitor their employees for exposure to chemicals which are used in bulk quantity, even if no one touches. It is like if you are working at nuclear power station, all employees are screened for radiation dosage so that atleast monitoring and data collection can help minute contamination or leakage.

 

[Anonymous]

not when it's all been FIPNetted away in a whirlwind of plausible deniability.'Why, they just weren't following our rigorous exposure monitoring standards...We are SHOCKED...SHOCKED!!'